Lucid Diagnostics (LUCD) Gross Profit (2021 - 2026)
Lucid Diagnostics (LUCD) posted Gross Profit of -$325000.0 for Q1 2026, up 10.22% on a QoQ basis from -$362000.0 in Q4 2025, and up 55.05% year-over-year from -$209612.0 in Q1 2025.
Lucid Diagnostics (LUCD) Gross Profit (2021 - 2026) Analysis & Trends
Lucid Diagnostics' Gross Profit history runs 6 years deep, the most recent figure standing at -$325000.0 for Q1 2026.
- Quarterly Gross Profit rose 55.05% year-over-year to -$325000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 45.55% YoY) and the FY2025 annual result came in at -$2.0 million, up 28.44% from the prior year.
- Gross Profit was -$325000.0 for Q1 2026 at Lucid Diagnostics, up from -$362000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $112000.0 in Q4 2022 and bottomed at -$1.4 million in Q2 2023.
- A 5-year average of -$534625.0 and a median of -$499000.0 in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit sank 1219.74% — and 2025, when it jumped 61.81%.
- Lucid Diagnostics' Gross Profit stood at $112000.0 in 2022, then sank by 472.32% to -$417000.0 in 2023, then tumbled by 127.34% to -$948000.0 in 2024, then soared by 61.81% to -$362000.0 in 2025, then climbed by 10.22% to -$325000.0 in 2026.
- Business Quant data shows LUCD's Gross Profit at -$325000.0 in Q1 2026, -$362000.0 in Q4 2025, and -$486000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325,000.00 |
| Mar 31, 2026 | -325,000.00 |
| Dec 31, 2025 | -362,000.00 |
| Dec 31, 2025 | -362,000.00 |
| Sep 30, 2025 | -486,000.00 |
| Sep 30, 2025 | -486,000.00 |
| Jun 30, 2025 | -363,000.00 |
| Jun 30, 2025 | -363,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | -948,000.00 |
| Dec 31, 2024 | -948,000.00 |
| Sep 30, 2024 | -512,000.00 |
| Sep 30, 2024 | -512,000.00 |
| Jun 30, 2024 | -638,000.00 |
| Jun 30, 2024 | -638,000.00 |
| Mar 31, 2024 | -655,000.00 |
| Mar 31, 2024 | -655,000.00 |
| Dec 31, 2023 | -417,000.00 |
| Dec 31, 2023 | -417,000.00 |